XBB.1.16‐RBD‐based trimeric protein vaccine can effectively inhibit XBB.1.16‐included XBB subvariant infection

XBB.1.16‐RBD‐based trimeric protein vaccine can effectively inhibit XBB.1.16‐included XBB subvariant infection

Abstract The newly identified XBB.1.16‐containing sublineages, including XBB.1.5, have become the prevailing severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant in circulation. Unlike previous Omicron XBB variants (e.g., XBB.1.5 and XBB.1.9) harboring the F486P substitution, XBB.1.1...

Full description

Bibliographic Details
Main Authors: Dandan Peng, Cai He, Zimin Chen, Hong Lei, Xiya Huang, Chunjun Ye, Binhan Wang, Ying Hao, Xinyi Du, Shuaiyao Lu, Hongbo Hu, Wei Cheng, Haohao Dong, Jian Lei, Xikun Zhou, Xiangrong Song, Guangwen Lu, Xiawei Wei
Format: Article
Language:English
Published: Wiley 2024-09-01
Series:MedComm
Subjects:
heterologous booster
recombinant RBD‐HR protein
XBB.1.16 variant
Online Access:https://doi.org/10.1002/mco2.687

Internet

https://doi.org/10.1002/mco2.687

Similar Items